Daniel Fero

Daniel Fero is the Managing Director at OMX Ventures, a position held since 2020. They also serve as a Board Observer at Inscripta, Inc. and have held several board roles, including at Cellsonics Inc. and ReAx Biotechnologies. Previously, Daniel worked as a Healthcare Venture Capital Investor at Merieux Equity Partners and was an Engagement Manager at L.E.K. Consulting. They have experience in political operations and hold a BA from Rhode Island College and a PhD from the University of California, San Diego.